Pathophysiology of primary hyperparathyroidism

Histology and Histopathology

Volumn 15, Issue 2, 2000, Pages 619-627

  Hellman, Per ^a,b   Carling, T ^a   Rask, L ^a   Akerstrom G ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Calcium receptor; Hypercalcemia; Hyperparathyroidism; Parathyroid; Tumor

Indexed keywords

CALCITONIN; CALCIUM CHANNEL STIMULATING AGENT; CALCIUM SENSING RECEPTOR; ESTROGEN; MEGALIN; PARATHYROID HORMONE; PHOSPHONIC ACID DERIVATIVE; RETINOL; STEROID HORMONE; VITAMIN D;

BONE ATROPHY; CALCIUM BLOOD LEVEL; CELL PROLIFERATION; CELL SURFACE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HORMONAL REGULATION; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; KIDNEY FAILURE; PARATHYROID GLAND; PARATHYROID HORMONE RELEASE; PRIMARY HYPERPARATHYROIDISM; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SOFT TISSUE CALCIFICATION;

ANIMALS; FEMALE; HUMANS; HYPERPARATHYROIDISM; PARATHYROID HORMONE; RATS;

EID: 0034001510     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (91)

1. Agarwal S.K., Guru S.C., Heppner C., Erdos M.R., Collins P.M., Park S.Y., Saggar S., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., Marx S.J. and Burns A.L. (1999). Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96, 143-152.
2. Åkerström G., Malmaeus J., Grimelius L., Ljunghall S. and Bergström R. (1984). Histological changes in parathyroid glands in subclinical and clinical renal disease. Scand. J. Urol. Nephrol. 18, 75-81.
3. Åkerström G., Rudberg C., Grimelius L., Bergström R., Johansson H., Ljunghall S. and Rastad J. (1986). Histologic parathyroid abnormalities in an autopsy series. Hum. Pathol. 17, 520-527.
4. Arnold A. (1994). Molecular basis of primary hyperparathyroidism. In: The parathyroids. Levine M.A. and Bilezikian J.P. (eds). Raven Press, Ltd. New York, NY. pp 407-421.
5. Arnold A., Brown M., Urena P., Gaz R., Sarfati E. and Drueke T. (1995). Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J. Clin. Invest. 95, 2047-2053.
6. Arnold A., Staunton C.E., Kim H.G., Gaz R.D. and Kronenberg H.M. (1988). Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N. Engl. J. Med. 318, 658-662.
7. 2+ store release. J. Biol. Chem. 273, 21267-21275.
8. 3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells acking the vitamin D receptor. J. Bone Min. Res. 6, 1269-1275.
9. Bikle D.D., Ratnam A., Mauro T., Harris J. and Pillai S. (1996). Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J. Clin. Invest. 97, 1085-1093.
10. Bouillon R., Okamura W.H. and Norman A.W. (1995). Structure-Function relationships in the vitamin D endocrine system. Endocrine Rev. 16, 200-257.
11. Brown E. (1982). PTH secretion in vivo and in vitro. Regulation by calcium and other secretagogues. Miner Electrolyte Metab. 8, 130-150.
12. Brown E.M. (1983). Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J. Clin. Endocrinol. Metab. 56, 572-581.
13. 2+-receptor-mediated regulation of parathyroid and renal function. Am. J. Med. Sci. 312, 99-109.
14. 2+)-sensing receptor from bovine parathyroid. Nature 366, 575-580.
15. Brown E.M., Gardner D.G., Brennan M.F., Marx S.J., Spiegel A.M., Attie M.F., Downs Jr R.W., Doppman J.L. and Aurbach G.D. (1979). Calcium-regulated parathyroid hormone release in primary hyperparathyroidism: Studies in vitro with dispersed parathyroid cells. Am. J. Med. 66, 923-931.
16. 3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture. Endocrinology 117, 2114-2119.
17. 3 [In Process Citation]. Crit. Rev. Eukaryot. Gene Expr. 8, 19-42.
18. Carling T., Correa P., Hessman O., Hedberg J., Skogseid B., Lindberg D., Rastad J., Westin G. and Akerstrom G. (1998). Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism [see comments], J. Clin. Endocrinol. Metab. 83, 2960-2963.
19. Carling T., Kindmark A., Hellman P., Lundgren E., Ljunghall S., Rastad J., Åkerström G. and Melhus H. (1995). Vitamin D genotypes in hyperparathyroidism. Nature Med. 1, 1309-1311.
20. Carling T., Rastad J., Ridefelt P., Gobi A., Hellman P., Öberg K., Rask L., Larsson C., Juhlin C., Åkerström G. and Skogseid B. (1995). Hyperparathyroidism of multiple endocrine neoplasia type 1: Candidate gene and parathyroid calcium sensing protein expression. Surgery 118, 924-931.
21. Carling T., Rastad J., Åkerström G. and Westin G. (1998). Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. J. Clin. Endocrinol. Metab. 83, 2255-2259.
22. Carling T., Ridefelt P., Hellman P., Rastad J. and Åkerström G. (1997). Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 82, 1772-1775.
23. Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.-E., Collins F.S., Emmert-Buck M.R., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weisemann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim Y.S., Heppner C., Dong Q., Spiegel A.M., Burns A.L. and Marx S.J. (1997). Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276, 404-407.
24. Cryns V.L., Yi S.M., Tahara H., Gaz R.D. and Arnold A. (1995). Frequent loss of chromosome 1p DNA in parathyroid adenomas. Gene. Chromosome Cancer 13, 9-17.
25. Delmez J.A., Tindira C., Grooms P., Dusso A., Windus D.W. and Slatopolsky E. (1989). Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J. Clin. Invest. 83, 1349-1355.
26. 3. Proc. Natl. Acad. Sci. USA 89, 8097-8101.
27. 2+ from non-mitochondrial pools by inositol trisphosphate. FEBS Lett. 188, 141-144.
28. Farnebo F., Enberg U., Grimelius L., Bäckdahl M., Schalling M., Larsson C. and Farnebo L.-O. (1997). Tumor specific decreased expression of calcium sensing receptor message ribonucleic acid in sporadic primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 82, 3481-3486.
29. Farnebo F., Teh B.T., Kytölä S., Svensson A., Phelan C., Sandelin K., Thompson N.W., Höög A., Weber G., Farnebo L.-O. and Larsson C. (1998). Alterations of the MEN 1 gene in sporadic parathyroid tumors. J. Clin. Endocrinol. Metab. 83, 2627-2630.
30. Farquhar M.G., Kerjaschki D., Lundstrom M. and Orlando R.A. (1994). Gp330 and RAP: The heymann nephritis antigenic complex. Ann. NY Acad. Sci. 737, 96-113.
31. Friedman E., Sakaguchi K., Bale A., Falchetti A., Streeten E., Zimering M., Weinstein L., McBride W., Nakamura Y. and Brandi M. (1989). Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N. Engl. J. Med. 321, 213-218.
32. Fujimi T., Baba H., Fukase M. and Fujita T. (1991). Direct inhibitory effect of aminoterminal parathyroid hormone fragment [PTH(1-34)] on PTH secretion from bovine parathyroid primary cultured cells in vitro. Biochem. Biophys. Res. Commun. 178, 953-958.
33. Garrett J.E., Tamir H., Kifor O., Simin R.T., Rogers K.V., Mithal A., Gagel R.F. and Brown E.M. (1995). Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 136, 5202-5211.
34. Grimelius L., Åkerström G., Johansson H., Ljunghall S. and Rastad J. (1986). The role of pathology in diagnosis and surgical decision-making. In: Progress in surgery. Eh H. (ed). S. Karger. Basel. pp 80-92.
35. Grossman R.F. and Jossart G.H. (1997). Hypercalcemic crisis. In: Textbook of endocrine surgery. Clark O.H. and Duh Q.-Y. (eds). W.B. Saunders Company. Philadelphia, PA. pp 432-438.
36. 2+ influx into parathyroid cells by external cation binding. In: Calcium regulation and bone metabolism: Basic and clinical aspects. Cohn D.V., Martin T.J. and Meunier P.J. (eds). Elsevier. Amsterdam, pp 33-38.
37. Gylfe E., Larsson R., Johansson H., Nygren P., Rastad J., Wallfelt C. and Åkerström G. (1986). Calcium-activated calcium permeability in parathyroid cells. FEBS Lett. 205, 132-136.
38. Habener J.F., Rosenblatt M. and Potts Jr J.T. (1984). Parathyroid hormone: Biochemical aspects of biosynthesis, secretion, action and metabolism. Physiol. Rev. 64, 985-1053.
39. Hedbäck G., Tisell L.-E., Bengtsson B.-A., Hedman I. and Oden A. (1990). Premature death in patients operated on for primary hyperparathyroidism. World J. Surg. 14, 829-835.
40. Hellman P., Åkerström G., Ljunghall S. and Rastad J. (1989). Surgical findings and results of subtotal and total parathyroidectomy in hypercalcemic patients with uremic hyperparathyroidism. Acta Chir. Scand. 155, 573-582.
41. Hellman P., Ridefelt P., Juhlin C., Åkerström G., Rastad J. and Gylfe E. (1992). Parathyroid-like regulation of parathyroid hormone-related protein release and cytoplasmic calcium in cytotrophoblast cells of human placenta. Arch. Biochem. Biophys 293, 174-180.
42. Hellman P., Åkerström G., Juhlin C., Ridefelt P. and Rastad J. (1994). Pathophysiology of hyperparathyroidism. In: Current controversy in parathyroid operation and reoperation. Åkerström G., Juhlin C. and Rastad J. (eds). R.G. Landes Company. Austin, TX, USA. pp 9-22.
43. 3-like molecule on normal and abnormal human parathyroid cells. Surgery 118, 1055-1062.
44. Hellman P., Ridefelt P., Björklund E., Yu W., Liu W., Tang S.-S., Juhlin C., Rastad J., Gylfe E., Lundgren S., Rask L., Ingelfinger J. and Åkerström G. (1995b). Cation sensing in a transformed rat proximal tubule cell line. Bone 16, S139.
45. Hellman P., Juhlin C., Karlsson-Parra A., Klareskog L., Lundgren S., Ridefelt P., Rastad J. and Åkerström G. (1996). Expression and function of a CD4-like molecule in normal and abnormal parathyroid cells - Relation to a calcium sensor molecule. Surgery 120, 985-992.
46. Hellman P., Liu W., Törmä H. and Åkerström G. (1998). Parathyroid cells are targets for retinoids. Bone 23, S452.
47. Hilpert J., Nykjaer A., Jacobsen C, Wallukat G., Nielsen R., Moestrup S.K., Haller H., Luft F.C., Christensen E.I. and Willnow I.E. (1999). Megalin antagonizes activation of the parathyroid hormone receptor. J. Biol. Chem. 274, 5620-5625.
48. 2+ binding receptor with potential intracellular signalling properties. Eur. J. Biochem. 239, 132-137.
49. Juhlin C., Holmdahl R., Johansson H., Rastad J., Åkerström G. and Klareskog L. (1987a). Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc. Natl. Acad. Sci. USA 84, 2990-2994.
50. 2+-sensor of human parathyroid cells. Biochem. Biophys. Res. Commun. 143, 570-574.
51. Juhlin C., Klareskog L., Nygren P., Ljunghall S., Gylfe E., Rastad J. and Åkerström G. (1988). Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology 122, 2999-3001.
52. 2+ in cytotrophoblast cells of human placenta. J. Biol. Chem. 265, 8275-8279.
53. Jüppner H., Abou-Samra A.-B., Freeman M., Kong X.F., Schipani E., Richards J., Kolakowski Jr L.F., Hock J., Potts Jr J.T., Kronenberg H.M. and Segre G.V. (1991). A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254, 1024-1026.
54. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J. Clin. Endocrinol. Metab. 81, 1598-1606.
55. 2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J. Bone Miner. Res. 12, 715-725.
56. Kremer R., Bolivar I., Goltzman D. and Hendy G.N. (1989). Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125, 935-941.
57. 2+ activity in parathyroid cells from patients with hyperparathyroidism. Bioscience Rep. 4, 909-915.
58. Liu W., Hellman P., Li Q., Yu W.-R., Juhlin C., Nordlinder H., Rollman O., Åkerström G., Törmä H. and Melhus H. (1996). Biosynthesis and function of all-trans-and 9-cis-retinoic acid in parathyroid cells. Biochem. Biophys. Res. Commun. 229, 922-929.
59. Lopez-Barneo J. and Armstrong C.M. (1983). Depolarizing response of rat parathyroid cells to divalent cations. J. Gen. Physiol. 82, 269-294.
60. Lundgren E., Ljunghall S., Åkerström G., Hetta J., Mallmin H. and Rastad J. (1998). Case-control study on symptoms and signs of "asymptomatic" primary hyperparathyroidism. Surgery 124, 980-986.
61. 2+ sensing properties the 550 kDa calcium sensor protein. J. Histochem. Cytochem. 45, 383-392.
62. Lundgren S., Hjälm G., Hellman P., Ek B., Juhlin C., Rastad J., Klareskog L., Åkerström G. and Rask L. (1994). A protein involved in calcium sensing of the human parathyroid and placental cytotrophoblast cells belonging to the LDL-receptor superfamily. Exp. Cell Res. 212, 344-350.
63. MacDonald P.N., Ritter C., Brown A.J. and Slatoposlky E. (1994). Retinoic acid suppresses parathyroid hormone (PTH) secretion and preproPTH mRNA levels in bovine parathyroid cell culture. J. Clin. Invest. 93, 725-730.
64. Martin K.J. and Slatopolsky E. (1994). The parathyroids in renal disease. Pathophysiology. In: The parathyroids. Bilezekian J.P., Levina M.A. and Marcus R. (eds). Raven Press Ltd. New York. pp 711-719.
65. McKay C. and Miller A. (1996). Relationship among cellular diacylglycerol, sphingosine formation, protein kinase C activity, and parathyroid hormone secretion from dispersed bovine parathyroid cells. Endocrinology 137, 2473-2479.
66. Morrison N.A., Cheng Qi J., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., Sambrook P.N. and Eisman J.A. (1994). Prediction of bone density from vitamin D receptor alleles. Nature 367, 284-287.
67. Naveh-Many T., Rahamimov R., Livni N. and Silver J. (1995). Parathyroid cell proliferation in normal and chronic renal failure rats. The effect of calcium, phosphate and vitamin D. J. Clin. Invest. 96, 1786-1793.
68. 2+ and the regulation of secretion in parathyroid cells. FEBS Lett. 203, 15-19.
69. Nemeth E., Steffey M.E., Hammerland L.G., Hung B.C., van Wagenen B.C., DelMAr E.G. and Balandrin M.F. (1998). Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc. Natl. Acad. Sci. USA 95, 4040-4045.
70. 3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif. Tissue Int. 43, 213-218.
71. 3. Cell 96, 507-15.
72. Okazaki T., Ando K., Igarshi T., Ogata E. and Fujita T. (1992). Conserved mechanism of negative gene regulation by extracellular calcium. J. Clin. Invest. 89, 1268-1273.
73. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75, 1297-1303.
74. Pollak M.R., Wu Chou Y.-H., Marx S.J., Steinmann B., Cole D.E.C., Brandi M.L., Papapoulos S.E., Menko F.H., Hendy G.N., Brown E.M., Seidman C.E. and Seidman J.G. (1994). Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J. Clin. Invest. 93, 1108-1112.
75. Racke F.K. and Nemeth E.F. (1993). Protein kinase C modulates hormone secretion regulated by extracellular polycations in bovine parathyroid cells. J. Physiol. 468, 163-176.
76. 2+ sensing of normal and adenomatous parathyroid cells. Mol. Cell. Endocrinol. 83, 211-218.
77. Ridefelt P., Nygren P., Hellman P., Larsson R., Rastad J., Åkerström G. and Gylfe E. (1992b). Regulation of parathyroid hormone release in normal and pathological parathyroid cells exposed to modulators of protein kinase C. Acta Endocrinol. 126, 505-509.
78. 2+ oscillations in parathyroid cells. Biochem. Biophys. Res. Commun. 215, 903-909.
79. 2+ and hormone secretion of parathyroid cells. Pharmacol. Toxicol. 78, 147-153.
80. Ruat M., Molliver M.E., Snowman A.M. and Snyder S.H. (1995). Calcium sensing receptor: molecular cloning in rat and localization to nerve terminals. Proc. Natl. Acad. Sci. USA 92, 3161-3165.
81. Saito A., Pietromonaco S., Kwor-Chieh Loo A. and Farquhar M.G. (1994). Complete cloning and sequencing of rat gp330/"megalin", a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. USA 91, 9725-9731.
82. Shivji F., Cheng H., Zwiers H., Hollenberg H. and Hanley D. (1996). Identification of classical, novel, and atypical protein kinase C isoenzymes in the bovine parathyroid. Endocrinology 137, 3777-3783.
83. Shoback D., Membreno L. and McGhee J. (1988). High calcium and other divalent cations increase inositol triphosphate in bovine parathyroid cells. Endocrinology 123, 283-289.
84. Silver J., Russell J. and Sherwood L.M. (1985). Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc. Natl. Acad. Sci. USA 82, 4270-4273.
85. Szabo J., Heath B., Hill V.M., Lackson C.E., Zarbo R.J., Mallette L.E., Chew S.L., Besser G.M., Thakker R.V. and Huff V. (1995). Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am. J. Hum. Genet. 56, 944-950.
86. Tang S.-S., Jung F., Diamant D., Brown D., Bachinsky D., Hellman P. and Ingelfinger J. (1995). Temperature-sensitive SV40 immortalized rat proximal tubule cell line has functional renin-angiotensin system. Am. J. Physiol. 268, F435-F446.
87. Tominaga Y., Kohara S., Namii Y., Nagasaka T., Haba T., Uchida K., Numano M., Tanaka Y. and Takagi H. (1996). Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J. Surg. 20, 744-752.
88. Wallfelt C., Gylfe E., Larsson R., Ljunghall S., Rastad J. and Åkerström G. (1988a). Relationship between external and cytoplasmic calcium concentrations, parathyroid hormone release and weight of parathyroid glands in human hyperparathyroidism. J. Endocrinol. 116, 457-464.
89. Wallfelt C., Larsson R., Gylfe E., Ljunghall S., Rastad J. and Åkerström G. (1988b). Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: Implications for parathyroid autotransplantation. World J. Surg. 12, 431-436.
90. Vieth R. (1990). The mechanisms of vitamin D toxicity. Bone Miner. 11, 267-272.
91. Willnow T., Hilpert J., Armstrong S., Rohlmann A., Hammer R., Burns D. and Herz J. (1996). Defective forebrain development in mice lacking gp330/megalin. Proc. Natl. Acad. Sci. USA 93, 8460-8464.